News

Traders are getting concerned about froth in the market, according to a new survey from Schwab.

Medical device company Merit Medical Systems (NASDAQ:MMSI) beat Wall Street’s revenue expectations in Q4 CY2024, with sales up 9.4% year on year to $355.2 million. The company expects the full year’s revenue to be around $1.48 billion, close to analysts’ estimates. Its non-GAAP profit of $0.93 per share was 12.2% above analysts’ consensus estimates.

Database as a service company Couchbase (NASDAQ: BASE) reported revenue ahead of Wall Street’s expectations in Q4 CY2024, with sales up 9.6% year on year to $54.92 million. On the other hand, next quarter’s revenue guidance of $55.5 million was less impressive, coming in 1.9% below analysts’ estimates. Its non-GAAP loss of $0 per share was significantly above analysts’ consensus estimates.

Restaurant software company (NYSE:OLO) reported Q4 CY2024 results topping the market’s revenue expectations, with sales up 20.7% year on year to $76.07 million. Guidance for next quarter’s revenue was better than expected at $77.45 million at the midpoint, 1.4% above analysts’ estimates. Its non-GAAP profit of $0.06 per share was in line with analysts’ consensus estimates.

The ultimate “Trump trade” has run into trouble.

Fragrance and perfume company Inter Parfums (NASDAQ:IPAR) met Wall Street’s revenue expectations in Q4 CY2024, with sales up 10% year on year to $361.5 million. The company’s outlook for the full year was close to analysts’ estimates with revenue guided to $1.51 billion at the midpoint. Its GAAP profit of $0.75 per share was 5.7% below analysts’ consensus estimates.

Discount grocery store chain Grocery Outlet (NASDAQ:GO) announced better-than-expected revenue in Q4 CY2024, with sales up 10.9% year on year to $1.10 billion. The company expects the full year’s revenue to be around $4.75 billion, close to analysts’ estimates. Its non-GAAP profit of $0.15 per share was 10.3% below analysts’ consensus estimates.